This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen acción 2118
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.37 |
| 52 Week High | CN¥2.98 |
| 52 Week Low | CN¥0.37 |
| Beta | 0.46 |
| 1 Month Change | 0% |
| 3 Month Change | -76.88% |
| 1 Year Change | -85.43% |
| 3 Year Change | -92.04% |
| 5 Year Change | -93.32% |
| Change since IPO | -73.04% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 2118 | CN Pharmaceuticals | Mercado CN | |
|---|---|---|---|
| 7D | 0% | -2.0% | -2.7% |
| 1Y | -85.4% | -17.1% | -18.2% |
Rentabilidad vs. Industria: 002118 underperformed the CN Pharmaceuticals industry which returned -1.6% over the past year.
Rentabilidad vs. Mercado: 002118 underperformed the CN Market which returned -4.4% over the past year.
Volatilidad de los precios
| 2118 volatility | |
|---|---|
| 2118 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 11.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 002118's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine 002118's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1998 | 842 | Youshun Feng | www.jilinzixin.com.cn |
Resumen de fundamentos de Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
| Estadísticas fundamentales de 2118 | |
|---|---|
| Capitalización bursátil | CN¥473.88m |
| Beneficios(TTM) | -CN¥1.19b |
| Ingresos (TTM) | CN¥149.92m |
3.2x
Ratio precio-ventas (PS)-0.4x
Ratio precio-beneficio (PE)¿Está 2118 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 2118 | |
|---|---|
| Ingresos | CN¥149.92m |
| Coste de los ingresos | CN¥63.88m |
| Beneficio bruto | CN¥86.04m |
| Otros gastos | CN¥1.28b |
| Beneficios | -CN¥1.19b |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
Aug 23, 2023
| Beneficios por acción (BPA) | -0.93 |
| Margen bruto | 57.39% |
| Margen de beneficio neto | -793.41% |
| Ratio deuda/patrimonio | 497.1% |
¿Cómo se ha desempeñado 2118 a largo plazo?
Ver rendimiento histórico y comparativa